Applies to cemiplimab: intravenous solution.
Serious side effects of Cemiplimab
Along with its needed effects, cemiplimab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking cemiplimab:
More common
- Chills
- cough
- diarrhea
- fever
- hoarseness
- itching, skin rash
- lower back or side pain
- painful or difficult urination
Less common
- Bladder pain
- bloody or cloudy urine
- blurred vision
- body aches or pain
- chest pain, discomfort, or tightness
- confusion
- dark urine
- dizziness
- ear congestion
- fainting
- frequent urge to urinate
- general feeling of discomfort or illness
- headache
- light-colored stools
- lightheadedness
- loss of voice
- muscle or bone pain
- muscle weakness
- nausea
- nervousness
- pain, redness, swelling, tenderness, or warmth on the skin
- pale skin
- pounding in the ears
- rapid, shallow breathing
- runny or stuffy nose
- slow or fast heartbeat
- sneezing
- sore throat
- stiff neck or back
- thickening of bronchial secretions
- trouble breathing
- unusual bleeding or bruising
- unusual tiredness or weakness
- upper right stomach pain
- vomiting
- yellow eyes and skin
Rare
- Blistering, peeling, or loosening of the skin
- difficulty in moving
- joint or muscle pain
- muscle aches, cramps, or stiffness
- red skin lesions, often with a purple center
- red, irritated eyes
- sores, ulcers, or white spots in the mouth or on the lips
- swollen glands
- swollen joints
Other side effects of Cemiplimab
Some side effects of cemiplimab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Abnormal or decreased touch sensation
- burning, crawling, itching, numbness, prickling, "pins and needles", tingling, or painful feelings
- constipation
- decreased appetite
- loss or thinning of the hair
- trouble sleeping
- unsteadiness or awkwardness
- weakness in the arms, hands, legs, or feet
For Healthcare Professionals
Applies to cemiplimab: intravenous solution.
Ocular
Uncommon (0.1% to 1%): Uveitis, iritis, retinal detachment, visual impairment, blindness[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Myocarditis, pericarditis, vasculitis[Ref]
Dermatologic
Very common (10% or more): Rash (e.g., maculopapular rash, dermatitis, generalized rash, dermatitis bullous, drug eruption, erythema, erythematous rash, macular rash, pruritic rash, skin reaction) (25%), pruritus (15%)[Ref]
Endocrine
Common (1% to 10%): Hypothyroidism, hyperthyroidism
Uncommon (0.1% to 1%): Adrenal insufficiency, hypophysitis, thyroiditis[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea/colitis (22%), nausea (19%), constipation (12%)
Uncommon (0.1% to 1%): Colitis, pancreatitis[Ref]
Immunologic
Common (1% to 10%): Immunogenicity
Uncommon (0.1% to 1%): Sjogren's syndrome, immune thrombocytopenic purpura[Ref]
Local
Uncommon (0.1% to 1%): Infusion-related reactions[Ref]
Metabolic
Very common (10% or more): Decreased appetite (10%)
Uncommon (0.1% to 1%): Type 1 diabetes mellitus, myositis, rhabdomyolysis, arthritis, polymyalgia rheumatica[Ref]
Musculoskeletal
Very common (10% or more): Musculoskeletal pain (e.g., back pain, myalgia, neck pain, pain in extremity (17%)
Common (1% to 10%: Arthralgia, arthritis, muscular weakness[Ref]
Nervous system
Uncommon (0.1% to 1%): Meningitis, encephalitis, myelitis and demyelination, myasthenic syndrome/myasthenia gravis, Guillain-Barre syndrome, nerve paresis, autoimmune neuropathy, central nervous system inflammation, neuropathy peripheral, chronic inflammatory demyelinating polyradiculoneuropathy, Myasthenia gravis[Ref]
Other
Very common (10% or more): Fatigue/asthenia (29%)[Ref]
Respiratory
Common (1% to 10%): Pneumonitis[Ref]
Hepatic
Common (1% to 10%): Hepatitis[Ref]
Renal
Uncommon (0.1% to 1%): Nephritis, renal failure[Ref]
